XML 1100 R13.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Shareholders' Equity
 12 Months Ended
Dec. 31, 2019
Shareholders' Equity [Abstract]  
Shareholders' Equity
Note F - Shareholders' Equity

The Company's Class A and Class B Common Stock has a stated value of approximately $.04 per share.  The Company paid a total of $5,857, or $0.40 per share, in dividends during 2019, $16,835, or $1.12 per share, during 2018 and $16,302, or $1.08 per share, during 2017.

On August 31, 2017, the Company's Board of Directors authorized the reinstatement of its share repurchase program for up to 2,464,209 shares of the Company's Class A or Class B Common Stock.  On August 6, 2019, the Company's Board of Directors reaffirmed its share repurchase program, but also provided that the aggregate dollar amount of shares of the Company's Common Stock that may be repurchased under the share repurchase program between August 6, 2019 and August 6, 2020 may not exceed $25,000 and added a limit of no more than $6,250 in repurchases per quarter.  Pursuant to this share repurchase program, the Company entered into a Rule 10b5-1 plan on December 30, 2019 (the "Rule 10b5-1 Plan"), which authorized the repurchase of up to $625 of the Company's outstanding common shares at various pricing thresholds, in accordance with guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.  The Rule 10b5-1 Plan expired on February 26, 2020. No duration has been placed on the Company's share repurchase program, and the Company reserves the right to amend, suspend or discontinue it at any time.  The share repurchase program does not commit the Company to repurchase any shares of its Common Stock.

During the year ended December 31, 2019, the Company paid $11,501 to repurchase 11,989 shares of Class A Common Stock at an average share price of $15.70 and 665,099 shares of Class B Common Stock at an average share price of $17.01 under the share repurchase program.

Accumulated Other Comprehensive Income (Loss)

A reconciliation of the components of accumulated other comprehensive income (loss) at December 31, 2019, 2018 and 2017 is as follows:

  
2019
  
2018
 
Investments:
      
Total unrealized gain (loss) before federal income tax expense (benefit)
 
$
12,491
  
$
(7,859
)
Deferred tax benefit (liability)
  
(2,628
)
  
1,651
 
Net unrealized gains (losses) on investments
  
9,863
   
(6,208
)
         
Foreign exchange adjustment:
        
Total unrealized losses
  
(625
)
  
(1,442
)
Deferred tax benefit
  
131
   
303
 
Net unrealized losses on foreign exchange adjustment
  
(494
)
  
(1,139
)
         
Accumulated other comprehensive income (loss)
 
$
9,369
  
$
(7,347
)

Details of changes in net unrealized gains (losses) on investments for the years ended December 31, 2019, 2018 and 2017 are as follows:

  
2019
  
2018
  
2017
 
Investments:
         
Pre-tax holding gains (losses) on fixed income securities arising during period (1)
 
$
19,182
  
$
(12,253
)
 
$
26,677
 
Less: applicable federal income tax expense (benefit)
  
4,028
   
(2,573
)
  
9,337
 
   
15,154
   
(9,680
)
  
17,340
 
             
Pre-tax gains (losses) on fixed income securities included in net income (loss) during period (1)
  
(1,161)
   
(3,560
)
  
7,217
 
Less: applicable federal income tax expense (benefit)
  
(244)
   
(748
)
  
2,526
 
   
(917)
   
(2,812
)
  
4,691
 
             
Change in unrealized gains (losses) on investments
 
$
16,071
  
$
(6,868
)
 
$
12,649
 

(1)
Effective January 1, 2018, the Company adopted ASU 2016-01 and unrealized gains (losses) related to equity securities are no longer reflected in accumulated other comprehensive income (loss).  Prior periods have not been restated to conform to the current presentation.